Professional
Added to YB: 2024-05-03
Pitch date: 2024-04-26
MCK [bullish]
McKesson Corporation
+42.47%
current return
Author Info
No bio for this author
Company Info
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions.
Market Cap
$88.6B
Pitch Price
$538.00
Price Target
N/A
Dividend
0.44%
EV/EBITDA
12.75
P/E
19.21
EV/Sales
0.23
Sector
Health Care Providers and Services
Category
growth
ClearBridge Global Growth Strategy New Position: McKesson Corporation
MCK: Top US pharma distributor in stable oligopoly. Largest in fast-growing, high-margin specialty & oncology. Low-teens EPS growth potential w/ chance of multiple expansion on superior organic growth vs peers.
Read full article (1 min)